Zofran (onadnsetron) Birth Defect Lawsuits Mount as More Women Come Forward

Ashley Wright is one of dozens of women who have filed lawsuits against GlaxoSmithKline (“GSK”), maker of anti-nausea drug Zofran (ondansetron), and ten years later is finally speaking out about her experience after taking the drug. Zofran (ondansetron) was approved by the FDA to combat nausea and vomiting in cancer patients undergoing chemotherapy, but has been prescribed “off label” to treat similar symptoms related to morning sickness. Wright took Zofran (ondansetron) during her pregnancy with son Kaleb, who was born with a severe cleft palate. Elizabeth Graham, attorney from plaintiffs’ firm Grant & Eisenhofer, represents Wright and more than 200 families affected by Zofran (ondansetron) and GSK’s alleged misconduct. “They were telling the doctors this is a great anti-nausea drug, which we don’t dispute it, but what they weren’t saying is that they had never gotten approval for use in pregnant women because there were no tests,” Graham said.

Grant & Eisenhofer filed some of the first cases in the Zofran (ondansetron) multi-district litigation, and serves as co-lead on the Plaintiffs’ Executive Committee. If you or a loved one took Zofran (ondansetron) for morning sickness during your first trimester and your baby was born with a cleft palate or congenital heart defect, please contact us at 877-978-0169 for a confidential evaluation of your potential claim.

Real Time Analytics